An Introduction to Interventional Cardiology
Interventional cardiology involves the use of intravascular, catheter-based techniques to treat patients with cardiovascular disease. The field has seen significant advances over the past decade, such as new imaging technologies and devices.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer-reviewed articles from our journal portfolio.
Interventional Cardiology Content
Tabassome Simon, ESC 2020 – the REALITY Trial
We spoke to Professor Tabassome Simon (Hospital Saint-Antoine, Paris, France) on the background, aims and design of the REALITY study (REstrictive And LIberal Transfusion strategies in patients with acute mYocardial infarction and anemia; ClinicalTrials.gov identifier NCT02648113), as well as the findings of the study to date. Questions: How prevalent is anaemia in patients with myocardial […]
Imad Sheiban, ESC 2020 – Left Main Percutaneous Coronary Intervention Part 1
We spoke to Prof Imad Sheiban (Interventional Cardiology, P Pederzoli Hospital Peschiera del Garda, Verona, Italy) on the topic of left main angioplasty and percutaneous coronary intervention of the left main. Here, he provides a brief introduction. Part One: Introduction to Left Main Angioplasty Speaker disclosures: Professor Imad Sheiban has nothing to declare in relation […]
Imad Sheiban, ESC 2020 – Left Main Percutaneous Coronary Intervention Part 2
We spoke to Prof Imad Sheiban (Interventional Cardiology, P Pederzoli Hospital Peschiera del Garda, Verona, Italy) on the topic of left main angioplasty and percutaneous coronary intervention of the left main. Here, he answers our questions. Part Two: Questions In which patients is percutaneous coronary intervention (PCI) of left main coronary stenosis a safe alternative […]
The Coronary Sinus Reducer – Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina
Heart International. 2020;14(1):29-33 DOI: https://doi.org/10.17925/HI.2020.14.1.29
Refractory angina pectoris is a chronic disabling condition affecting an increasing number of patients (10–15%) with severe ischaemic heart disease.1 It is generally defined as the presence of debilitating angina due to severe and/or diffuse coronary artery disease (CAD), despite optimal medical therapy and with no option for further percutaneous or surgical revascularisation procedures. As […]
Clopidogrel-induced Pill Oesophagitis
Heart International. 2020;14(1):56-8 DOI: https://doi.org/10.17925/HI.2020.14.1.56
Antiplatelet agents are routinely given to prevent thrombosis of coronary stents.1 When antiplatelet drugs are not given before percutaneous coronary intervention (PCI), they may be given on the table during PCI.1 Ingestion of pills while supine on the catheterisation table often causes mild dysphagia and discomfort but, rarely, it can cause a more serious event. […]
Comparison of Contemporary Drug-eluting Coronary Stents – Is Any Stent Better than the Others?
Heart International. 2020;14(1):34-42 DOI: https://doi.org/10.17925/HI.2020.14.1.34
Coronary artery disease (CAD), due to development of atherosclerotic plaques, remains a leading cause of morbidity and mortality. If unstable or clinically significant, these are frequently treated with percutaneous coronary intervention (PCI), typically involving balloon angioplasty and implantation of a metallic drug-eluting stent (DES).1 Coronary stents have substantially evolved since their first use in the 1980s […]
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Left Main Revascularisation
Heart International. 2020;14(1):11-2 DOI: https://doi.org/10.17925/HI.2020.14.1.11
Left main (LM) coronary artery disease is the atherosclerotic narrowing of the LM segment, and is often associated with involvement of the ostial disease of the left anterior descending and left circumflex arteries, called distal LM disease. Significant LM disease is defined as ≥50% angiographically-detected stenosis of the LM or angiographically <50% stenosis with positive […]
A Review of the Ultrathin Orsiro Biodegradable Polymer Drug-eluting Stent in the Treatment of Coronary Artery Disease
Heart International. 2019;13(2):17–24
Coronary artery disease (CAD) is a major global cause of death attributing to nearly 9 million deaths worldwide in 2016.1 The introduction of percutaneous coronary intervention (PCI) has revolutionised the treatment of CAD in current clinical practice, and advances in coronary stent technology have continued to deliver improved outcomes. In recent years, there has been […]
Evaluating Equivocal Left Main Stenosis with Fractional Flow Reserve – Not all Daughter Vessels are Created Equally
Heart International. 2019;13(2):38–40
Fractional flow reserve (FFR) has been a useful tool in guiding decision-making in intermediate left main coronary artery (LMCA) stenosis, particularly in the absence of downstream disease.1 Multiple caveats have been raised about the use of FFR with significant downstream disease and the interpretation of the significance of the LMCA stenosis.2 On the other hand, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!